Background. While the genetic basis of autosomal dominant polycystic kidney disease (ADPKD) has been clearly established, the pathogenesis of renal 15 failure in ADPKD remains elusive. Cyst formation originates from proliferating renal tubular epithelial cells that de-differentiate. Fluid secretion with cyst expansion and reactive changes in the extracellular matrix composition combined with increased apoptosis 20 and proliferation rates have been implicated in cystogenesis.
Introduction

50
Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary disease, caused by mutations of either PKD1 or PKD2. The onset of the disease is poorly defined, but the findings of microcysts in embryonal kidneys suggest that cyst formation starts 55 during renal development (see [1] for a recent review) and progresses continuously in adulthood. Most individuals with PKD1 mutations experience renal failure in their fifth decade of life, while the onset of end-stage renal disease (ESRD) is delayed by about two 60 decades in patients with PKD2 mutations.
Polycystin-1, the protein encoded by PKD1, is a large integral membrane protein with a domain architecture suggesting a function in cell-cell or cell-matrix interaction [2] .
Polycystin-2 is a member of the calcium-permeable subfamily of TRP channels, and forms a complex with polycystin-1 [3, 4] . Both polycystin-1 and polycystin-2 are present in the primary cilium of tubular epithelial cells, and the raise in intracellular calcium mediated 70 by cilial bending requires the presence of both proteins [5] .
Despite these recent advances in understanding the function of polycystin-1 and polycystin-2, the pathogenesis of cyst formation and particularly, the 75 development of ESRD in ADPKD have remained elusive. Less-than-terminal differentiation of epithelial cells that line the cysts, persistent proliferation due to mislocalization of EGF receptors, stimulation of proto-oncogenes, and cyst expansion as a result to explain, why a few hundred cysts cause complete destruction of the renal parenchyma [6] . However, increased apoptosis rates detected in the normal tissue surrounding renal cysts suggest that additional 5 factors account for the progressive loss of renal function [7] . We chose cDNA microarrays to screen for mechanisms possibly involved in cyst formation and/or progression of the disease. Expression profiling 10 revealed smooth muscle actin (SMA), caldesmon, sarcospan-2, fibulin-1, 22 kDa smooth muscle protein and other genes involved in epithelial-to-myofibroblast transition (EMT) to be specifically up-regulated in ADPKD. RT-PCR and immunohistochemistry con-15 firmed our results on RNA and protein level and suggest that the absence of functional polycystins results in increased expression of EMT genes. 20 cDNA microarrays were produced and processed essentially according to the Stanford protocol described by Eisen and Brown [8] . Approximately 7000 annotated genes from the RZPD (Resource Center and Primary Database, Berlin, Germany) were obtained as bacterial stocks. Plasmids were 25 purified using the Qiagen 96-well Turbo Kit (Qiagen, Hilden, Germany), and inserts were purified by PCR using vector primers flanking the individual inserts (5 0 -CTG CAA GGC GAT TAA GTT GGG TAA C -3 0 and 5 0 -GTG AGC GGA TAA CAA TTT CAC ACA GGA AAC AGC-3 0 ). PCR 30 products were purified by ethanol precipitation and resuspended in H 2 O. Aliquots were transferred into 384-well plates, dried and resuspended in 3 Â SSC or DMSO 10% to a final concentration of $40 ng/ml. Printing was performed on aminosilane-coated slides (CMT-GAP II Slides, 35 Corning, NY, USA), using an arrayer that was assembled according to specifications by the Stanford group using software kindly provided by J. 
Subjects and methods
Microarrays
RNA preparation
Frozen tissue was homogenized in 4 M guanidinium iso-60 thiocyanate with 0.72% ß-mercaptoethanol using a polytron (PT-MR2100, Kinematica AG, Lucerne, Switzerland). Total RNA was subsequently purified on a cesiumchloride gradient. After ethanol precipitation, RNA was resuspended at a concentration of 0.4-4 mg/ml and stored at À80 C.
Hybridization
All hybridizations were performed in the presence of an equal amount of reference RNA (Stratagene, La Jolla, CA, USA) as published by Boldrick et al. [9] . was performed by adjusting the data to zero median and unit variance in order to obtain an identical distribution of the overall gene expression. Taking the mean of the expression values of the dye-swap experiments allows correction for dye-specific effects. Following an approach proposed by 90 Dudoit et al. [10] , the computed expression ratios should not depend on the intensity of the spots. Hence, a smooth non-linear least-squares fit was computed to correct for an intensity-dependent bias. A two sample t-test was used for a statistical analysis of differentially expressed genes. In order 95 to adjust the obtained P-values, the method by Benjamini and Hochberg [11] was applied to control for multiple testing. Hierarchical clustering was performed using the R-statistical software package (www.r-project.org).
Semiquantitative RT-PCR
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Total RNA (1mg) from all normal and polycystic kidneys was purified with the RNase free DNase set (Qiagen, Hilden, Germany), and reversely transcribed into cDNAs using oligo (dT) 12-18 primer and Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Each PCR was carried out The amplification cycle consisted of a hot start at 94 C for 5 min, followed by multiple cycles of denaturation at 94 C at 1 min, annealing at 58 C for 1 min and elongation at 72 C for 2 min. Cycle number was adjusted to mRNA expression 5 level of the different genes. The PCR products were run on a 3% agarose gel and evaluated in relation to the corresponding GAPDH band using Scion Image Software (Scion, Frederick, ML, USA).
Immunochemistry
10 Genes of different fold expression changes were randomly selected for validation by immunochemistry. Tissue samples were fixed in 4% paraformaldehyde, dehydrated and paraffinembedded. After rehydration procedure 10 mm tissue sections were incubated with 5% horse serum in phosphate-buffered 15 saline (PBS), pH7.4, for 1 h at room temperature and then incubated with the respective primary antibody, diluted in PBS-BSA 1%, for 16 h at 4 C. Sections were rinsed three times with PBS-BSA 1%, followed by incubation with the respective rhodamine-red conjugated secondary antibody for 20 30 min at room temperature. After extensive washing with PBS-BSA 1% stained sections were examined with a Zeiss microscope.
The following antibodies were used: affinity-purified murine monoclonal antibody against pancytokeratin, 25 affinity-purified murine monoclonal antibody against CD3 (used as negative control for murine monoclonal antibodies) (Sigma-Aldrich,Taufkirchen, Germany); horse serum and affinity-purified murine monoclonal antibodies against SMA, affinity-purified murine monoclonal antibody against 30 keratin 19 (DakoCytomation Hamburg, Germany); affinitypurified polyclonal antibody from goat against fibulin-1 (Santa Cruz, Heidelberg, Germany) and affinity-purified murine monoclonal antibody against caldesmon (Biomol, Hamburg, Germany), Rhodamine Red-X AP-conjugated 35 donkey anti-goat IgG, Rhodamine Red-X AP-conjugated goat anti-mouse (Dianova, Hamburg, Germany).
Results
Hierarchical TÂ1, TÂ5, TÂ7,  TÂ10, TÂ11, TÂ13, TÂ14) , and two normal kidneys clustered with the remaining five transplant kidneys TÂ2, TÂ3, TÂ4, TÂ6, TÂ8, TÂ9) . Thus, the dendrogram confirmed that the expression profile in end-stage ADPKD differs from normal kidneys, and is more closely related to other kidneys with ESRD. 5 Genes specific for polycystic kidney disease
Examining the functional categories of genes which distinguish ADPKD, we found a number of regulated genes coding for proteins involved in metabolism and homeostasis (n ¼ 24), signalling (n ¼ 18), adhesion/ 10 extracellular matrix (n ¼ 12), cytoskeletal proteins (n¼14), immune response (n ¼ 8), transcription (n ¼ 6), differentiation (n ¼ 1) and ion transport (n ¼ 1). The function of three genes is currently unknown ( Table 1) . ing very closely the microarray data (Figures 2 and 3) . GAPDH mRNA expression was used as internal control. 
Verification of differentially expressed candidate genes by immunochemistry
To further validate the expression profiles, we performed immunohistochemistry of selected gene 5 products. Paraformaldehyde-fixed sections of paraffinembedded tissue of four normal kidneys and four cystic kidneys were stained for SMA, caldesmon, fibulin-1 and keratin 19. Representative results for one patient are shown in Figure 4 . All four proteins 10 were present in both cystic kidneys as well as in normal renal tissues. Keratin 19 and fibulin-1 were confined to the epithelial cells lining the cysts. In the normal kidney, both proteins were observed only in a few tubules. Consistent with its strong up-regulation on micro-15 arrays, elevated SMA and caldesmon mRNA expression was accompanied by a dramatic increase in the protein level, mainly located in the enlarged interstitium of cystic kidneys, while SMA was restricted to vascular epithelium in the normal kidney. In addition 20 to the interstitial localization, caldesmon protein was also observed in cyst-lining epithelia in ADPKD kidneys as well as in a few discrete tubules in the normal kidney specimen.
Discussion
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Although the genetic defects leading to ADPKD have been elucidated, the process that underlies progressive cyst formation and renal failure are poorly understood (see [12] for recent review). To elucidate mechanisms associated with ESRD in ADPKD, we analysed 30 ADPKD kidneys that were removed during renal transplantation. To eliminate differential gene expression triggered by uraemia, we compared ADPKD kidneys with non-functional renal transplants. This approach eliminated genes with identical regulation 35 in ADPKD and chronic transplant failure. Using a threshold of >1.5-fold change in gene expression at a level of P<0.05, cDNA-microarray analysis Fig. 4 . Immunofluorescence of selected genes in normal and ADPKD kidneys. The staining pattern (Rhodamine Red) of representative areas in normal (A) and polycystic kidneys (B) are shown. In normal kidney tissue, fibulin-1, keratin 19 and pancytokeratin were detected only in some tubular epithelia, while these proteins were preferentially expressed in cystic epithelia of ADPKD kidneys. SMA and caldesmon were preferentially detected in the interstitium of ADPKD kidneys. revealed significant changes for 87 ADPKD-specific genes. Although the absolute changes in expression level may not reflect their biological significance, we focused on a subset of genes with either dramatic up-or 5 down-regulation. Cluster analysis confirmed that these genes depict a disease-specific gene expression pattern. A recent study by Husson et al. [13] compared the gene expression profiles of immortalized cell lines derived from either normal or cystic kidney epithelial 10 cells using serial analysis of gene expression (SAGE).
The 205 candidate genes identified with SAGE were subsequently used for a cDNA-microarray analysis comparing ADPKD and normal kidney tissue. The results show no overlap to our data. This is not 15 surprising, since Husson et al. [13] used cultured cell lines while we used tissue samples. In addition, the differences of the techniques used and the limited number of genes assessed by both methods may contribute to this discrepancy. 20 About 25% of the differentially regulated genes are encoded by cytoskeletal or matrix proteins as well as proteins involved in differentiation. Interestingly, a subset of genes belonged to smooth musclerelated genes suggesting that EMT contributes to the 25 progression of renal failure in ADPKD. One EMT marker, SM22, a protein expressed at early stages of EMT, revealed a 4.33-fold increase. Using immunohistochemistry, we confirmed the RNA-based expression data at the protein level. 30 EMT transdifferentiation has been implicated in the process of tubulointerstitial fibrosis, and appears to represent a final common pathway of progressive kidney failure. While myofibroblasts, typically expressing SMA, are rarely found in the interstitium of 35 normal kidneys, their number increases with disease progression, and correlates with the deterioration of renal function [14] . Growing evidence now suggests that interstitial myofibroblasts originate from tubular epithelial cells by EMT. EMT of human tubular 40 epithelial cells can be induced by TGF-ß [15] , and co-stimulation with EGF and TGF-ß induces expression of the myofibroblast-specific marker proteins, such as vimentin and FSP-1 [16] . Since cyst fluid of human ADPKD kidneys contains several growth factors, 45 including EGF, HGF, FGF-2 and TGF-ß [17] , the growth factor activities contained in cyst fluid could therefore directly trigger the EMT and the changes in gene expression reported in this study. Caldesmon, a cytoskeleton-associated protein typically present in smooth muscle thin filaments of differentiating smooth muscle cells, was up-regulated in the interstitium and the cyst-lining epithelia of 5 ADPKD kidneys. In IgA nephropathy, caldesmon expression correlates with advanced fibrosis [18] , suggesting that up-regulation of caldesmon in ADPKD coincides with the loss of normal renal tissue. Fibulin-1 is a calcium-binding glycoprotein, pro-10 duced by mesenchymal and endothelial cells. Fibulin-1 deficiency in knock-out mice is lethal, and homozygote animals die within 24-48 h after birth, due to massive haemorrhage and endothelial dysfunction. During organogenesis, fibulin-1 is detected in mesenchymal 15 cells involved in mesenchymal-to-epithelial transition [19] . In ADPKD kidneys, fibulin-1 was localized to cyst-lining epithelia. Since fibulin-1 interacts with the C-type lectin domains of versican and aggrican [20] , fibulin-1 could directly interact with the C-type lectin 20 present in the amino-terminal domain of polycystin-1.
Thus, up-regulation of fibulin-1 could be explained by either induction of EMT, or by a missing negative regulatory feedback signal, normally triggered by an interaction between fibulin-1 and polycystin-1. 25 A second member of the fibulin family, fibulin 4 was up-regulated in ADPKD. Fibulin-4 is found in the medial layers of large veins and arteries and in some small capillaries. Although the up-regulation of smooth muscle and cytoskeletal proteins in ADPKD 30 kidneys likely plays no role in cyst development, the accelerated EMT in ADPKD appears to contribute to the progression of renal failure and development of ESRD in ADPKD. Growth activities contained in cyst fluid may directly contribute to EMT and the progres-35 sive renal failure of ADPKD. Thus, therapeutic strategies directed to suppress EMT may ameliorate the clinical course of polycystic kidney disease. In addition, up-regulation of other hormone and growth factor receptors such as prostaglandin E, endothelin 40 and serotonin receptor may point to additional therapeutic targets to prevent cyst progression.
